These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2561525)

  • 1. [Clinico-epidemiologic and laboratory studies of patients with primary hepatocellular carcinoma].
    Ivan A; Dăneţ D; Iancu L; Tiron S; Ungureanu A; Zavate O
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):735-40. PubMed ID: 2561525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
    Roberts SK; Kemp W
    J Gastroenterol Hepatol; 2007 Feb; 22(2):191-6. PubMed ID: 17295870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiological factor of hepatocellular carcinoma in Italy.
    Stroffolini T
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in Nigerian children.
    Akinyinka OO; Falade AG; Ogunbiyi O; Johnson AO
    Ann Trop Paediatr; 2001 Jun; 21(2):165-8. PubMed ID: 11471262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects.
    Zaman S; Khan M; Alam K; Williams R
    J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
    Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in cirrhotic patients: role of hepatitis B virus.
    Leandro G; Colloredo G; Cozzolongo R; Elba S
    Ital J Gastroenterol; 1990 Apr; 22(2):66-9. PubMed ID: 1966704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of liver diseases in Korea: hepatocellular carcinoma.
    Song IH; Kim KS
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S50-9. PubMed ID: 20037280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.
    Donato F; Tagger A; Chiesa R; Ribero ML; Tomasoni V; Fasola M; Gelatti U; Portera G; Boffetta P; Nardi G
    Hepatology; 1997 Sep; 26(3):579-84. PubMed ID: 9303486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.